论文部分内容阅读
近两年,中国在医药研发创新上发生了很大变化。在创新投入上,2015年中国生物医药研发投入530亿元,增速全球最快。但是,中国目前绝大多数创新仍是渐进性的创新,缺乏真正的原发创新。日前,在第八届中国医药企业家年会上,麦肯锡发布的《构建可持续发展的中国医药创新生态系统》报告显示,如果不能在今后10年调整医药产业结构,建立起创新产业链,中国医药产业发展将后劲不足。
In the past two years, great changes have taken place in the innovation of pharmaceutical research and development in China. In terms of innovation input, China’s biomedical research and development invested 53 billion yuan in 2015, the fastest growth rate in the world. However, the vast majority of innovations in China are still gradual innovations, lacking genuine primary innovations. Recently, at the 8th Annual Meeting of Chinese Medical Entrepreneurs, McKinsey released a report entitled “Building a Sustainable Chinese Pharmaceutical Innovation Ecosystem”. If we can not adjust the pharmaceutical industry structure and establish an innovative industrial chain in the next 10 years, China The development of the pharmaceutical industry will be less than stamina.